Xenon Pharmaceuticals Inc. (39) | Collaboration Agreements (2)
Recent Contracts
-
Amendment #2, dated February 25, 2022, to the License and Collaboration Agreement, dated December 2, 2019, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc
(Filed With SEC on March 1, 2022)
-
Amendment #1, dated January 13, 2021, to the License and Collaboration Agreement, dated December 2, 2019, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc
(Filed With SEC on January 14, 2021)
